Concepedia

Longfeng Zhang

LZ

Statistics

Publications

20

Citations

478

H-Index

15

Active since

2019

Affiliations

Fujian Medical University(Current)

Fujian Provincial Cancer Hospital

Chinese Academy of Agricultural Sciences

Harbin Veterinary Research Institute

Union Hospital

Longfeng Zhang is an author at Fujian Medical University specializing in oncology, immunology, and viral infections.

Publications per year

2019–2024

20

Publications

20

Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China

Hongfu Cai, Longfeng Zhang, Na Li et al. · Clinical Therapeutics · 2019 · 51 citations

, , +12

Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost–effectiveness analysis

Hongfu Cai, Longfeng Zhang, Na Li et al. · Journal of Comparative Effectiveness Research · 2020 · 41 citations

, , +17

Vimentin inhibits type I interferon production by disrupting the TBK1-IKKε-IRF3 axis

Hongyang Liu, Guangqiang Ye, Xiaohong Liu et al. · Cell Reports · 2022 · 40 citations · Full text

, , +8

Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-κB and MAPK pathways

Ying Chu, Xiaowen Lv, Longfeng Zhang et al. · BMC Microbiology · 2020 · 38 citations · Full text

, , +17

First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis

Longfeng Zhang, Yongfu Hang, Maobai Liu et al. · Frontiers in Oncology · 2020 · 36 citations · Full text

, , +17

1–5 of 20